Oral Contrast Agent Market Overview by Recent Opportunities, Growth Size, Regional Analysis and Forecasts to 2027
The global oral contrast agent market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). Oral contrast agents are barium- or iodine-based. They are used for bowel opacification. Additionally, the concentration of barium determines if it enhances the diagnosis or causes an artifact and obscures pathology. The major factor driving the demand for oral contrast agent is the new product launches and drug approvals across the globe.
For instance, in December 2021,
Bayer announced the approval of two pediatric indications Xarelto (rivaroxaban)
from the US Food and Drug Administration (FDA). It is used for the treatment of
venous thromboembolism (VTE) and to reduce the risk of recurrent VTE in
patients from birth to less than 18 years after at least five days of initial
parenteral anticoagulant treatment and thromboprophylaxis in children aged two
years and older with congenital heart disease who have undergone the Fontan procedure.
Additionally, in December 2021, Ascelia Pharma AB presented a study in which
Orviglance was compared against a gadolinium-based contrast agent at RSNA 2021.
Orviglance is a novel manganese-based oral contrast agent for magnetic
resonance imaging (MRI).
To Request a Sample of our Report on Oral Contrast Agent
Market: https://www.omrglobal.com/request-sample/oral-contrast-agent-market
Some major players in the market include General Electric
Co., Bracco Imaging SpA, and Bayer AG, among others. The market players are
contributing significantly to the growth of the market by the adoption of
various strategies including mergers & acquisitions, geographical expansion,
partnerships and collaborations, and new product launches, to stay competitive
in the market. For instance, in December 2021, Ascelia Pharma AB announced the
acceptance of the Investigational New Drug (IND) application for the upcoming
global Phase 2 clinical study in gastric cancer with the daily oral
chemotherapy candidate drug Oncoral from the US Food and Drug Administration
(FDA).
Market Coverage
·
The market number available for – 2020-2027
·
Base year- 2020
·
Forecast period- 2021-2027
Segment Covered-
·
By Type
·
By Application
Regions Covered-
·
North America
·
Europe
·
Asia-Pacific
·
Rest of the World
Competitive Landscape- General Electric Co., Bracco
Imaging SpA, and Bayer AG, among others.
(Get 15% Discount on Buying this Report)
A
full Report of Oral Contrast Agent Market is Available @ https://www.omrglobal.com/industry-reports/oral-contrast-agent-market
Global Oral Contrast Agent Market Report by Segment
By Type
• Barium-based
Contrast Media
• Iodinated
Contrast Media
• Gadolinium-based
Contrast Media
• Microbubble
Contrast Media
By Application
• CVD
• Cancer
• Gastrointestinal
Disorders
• Musculoskeletal
Disorders
• Neurological
Disorders
• Nephrological
Disorders
Global Oral Contrast Agent Market Report by Region
North America
·
United States
·
Canada
Europe
·
UK
·
Germany
·
Spain
·
France
·
Italy
·
Rest of Europe
Asia-Pacific
·
India
·
China
·
Japan
·
South Korea
·
Rest of APAC
Rest of the World
·
Latin America
·
Middle East & Africa
Reasons to buy from us –
1. We cover more than
15 major industries, further segmented into more than 90 sectors.
2. More than 120
countries are for analysis.
3. Over 100+ paid
data sources mined for investigation.
4. Our expert
research analysts answer all your questions before and after purchasing your
report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company
known for its crisp and concise reports. The company is equipped with an
experienced team of analysts and consultants. OMR offers quality syndicated
research reports, customized research reports, consulting and other
research-based services.
Media
Contact:
Company
Name: Orion Market Research
Contact
Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact
no: +91 7803040404
Comments
Post a Comment